LncRNA NEAT1 promotes gastric cancer progression via miR-1294/AKT1 axis

被引:17
|
作者
Wu, Dianchao [1 ]
Li, Hui [1 ]
Wang, Junfeng [2 ]
Li, Hua [1 ]
Xiao, Qihai [1 ]
Zhao, Xiaofeng [1 ]
Huo, Zhibin [1 ]
机构
[1] Xingtai Peoples Hosp, Dept Surg Oncol, 16 Hongxing St, Xingtai 054031, Hebei, Peoples R China
[2] Tianjin Med Univ Canc Inst & Hosp, Dept Colorectal Surg, Tianjin, Peoples R China
来源
OPEN MEDICINE | 2020年 / 15卷 / 01期
关键词
NEAT1; gastric cancer; miR-1294; AKT1; PI3K/AKT/mTOR pathway; LONG NONCODING RNA; MIGRATION; INVASION; PROLIFERATION; EXPRESSION; GROWTH; CELLS;
D O I
10.1515/med-2020-0218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Long non-coding RNAs (lncRNAs) were reported to promote the development of gastric cancer (GC). Nuclear-enriched abundant transcript 1 (NEAT1) played a great role in diverse cancers, but the mechanism of NEAT1 in GC remains indistinct. NEAT1 and AKT1 were distinctly up-regulated and miR-1294 was down-regulated in GC tissues and cells. Cell proliferation and metastasis were refrained but apoptosis was promoted in GC cells after knockdown of NEAT1. NEAT1 negatively regulated miR-1294 expression, and the miR-1294 inhibitor reverted the si-NEAT1-induced effect on GC cells. NEAT1 modulated AKT1 expression through miR-1294, and the si-NEAT1-induced effect was relieved by AKT1. NEAT1 affected phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway via regulating miR-1294 and AKT1. NEAT1 could modulate cell proliferation, apoptosis, and metastasis in GC cells by regulating the PI3K/AKT/mTOR signaling pathway via the miR-1294/ AKT1 axis, showing the great potential for NEAT1 as a valid biomarker in the progression and treatment of GC.
引用
收藏
页码:1028 / 1038
页数:11
相关论文
共 50 条
  • [1] LncRNA NEAT1 Promotes the Progression of Gastric Cancer Through Modifying the miR-1224-5p/RSF1 Signaling Axis
    Yang, Luoluo
    Wang, Min
    He, Ping
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 11845 - 11855
  • [2] LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer by Targeting ZEB1 via miR-448
    Wu, Hanquan
    Dong, Dengwen
    Wang, Jiwei
    Yin, Shiwen
    Gong, Yuanxiang
    Yang, Chao
    Bai, Yihan
    Wang, Junyi
    Du, Yanhong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [3] lncRNA NEAT1 Promotes Colorectal Cancer Progression by Increasing Inflammation
    Chen, Qingmin
    Qin, Yi
    Lin, Min
    Li, Zhao
    Tang, Weizhong
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [4] LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1
    Li, Yabin
    Wang, Xirui
    Zhao, Zhihuang
    Shang, Jinxing
    Li, Gang
    Zhang, Ruijian
    BIOSCIENCE REPORTS, 2021, 41 (07)
  • [5] The lncRNA NEAT1 Promotes Radioresistance via the MiR-491-5p/CAPG Axis in NSCLC
    Zhou, S.
    Yang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S431 - S432
  • [6] LncRNA NEAT1 modulates sorafenib resistance in hepatocellular carcinoma through regulating the miR-149-5p/AKT1 axis
    Niu, Yuexiang
    Tang, Gongen
    Wu, Xiuli
    Wu, Chaoyu
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2020, 26 (04): : 194 - 203
  • [7] lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis
    Zhu, Lin
    Wang, Fengchun
    Fan, Wenhui
    Jin, Zhi
    Teng, Chao
    Zhang, Jianxin
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53 (09) : 1198 - 1206
  • [8] NEAT1 promotes retinoblastoma progression via modulating miR-124
    Wang, Lufei
    Yang, Defeng
    Tian, Rui
    Zhang, Hui
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (09) : 15585 - 15593
  • [9] LINC00473 PROMOTES LUNG ADENOCARCINOMA PROGRESSION BY REGULATING miR-1294/ROBO1 AXIS
    Wang, S.
    Wang, X.
    Xu, S. L.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (02): : 411 - 420
  • [10] LncRNA NEAT1 Promotes Gastric Cancer Progression Through miR-17-5p/TGFβR2 Axis Up-Regulated Angiogenesis
    Xu, Yangwei
    Li, Yanyan
    Qiu, Yue
    Sun, Fei
    Zhu, Guifang
    Sun, Jingbo
    Cai, Guixing
    Lin, Wanmei
    Fu, Yun
    Wu, Hongmei
    Jiang, Shanshan
    Wen, Zhihui
    Feng, Feiyan
    Luo, Junjie
    Yang, Yuqin
    Zhang, Qingling
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9